GLPwatch
Clinically significant emesis in a patient taking a long-acting GLP-1 receptor agonist for weight loss.
Br J Anaesth · 2023
Last updated 2026-07-14| Journal | Br J Anaesth, 2023 |
|---|---|
| Citations | 30 |
| Relative citation ratio | 4.22 |
| NIH percentile | 90 |
| Molecules | — |
| Conditions studied | Obesity |
Full record and abstract on PubMed 37302962 ↗